Feed formulators evaluating methionine sources often compare DL-methionine and MHA. The discussion usually centers on bioavailability and purity, not just headline price. A practical reading of the numbers shows why 100% bioavailability and 99% purity can shift the economics of a complete feed formulation.

DL-methionine is often treated as the reference standard. When a product is described as 100% bioavailable, it means the methionine activity is fully available to the animal, so formulation can be based on a direct replacement of digestible methionine. That simplifies least-cost formulation and reduces uncertainty around over- or under-formulation.

MHA, as an alternative methionine source, is often evaluated on a different basis. Because its methionine activity may be expressed differently and its conversion efficiency can vary, nutritionists need to compare like-for-like units rather than raw inclusion rates. The excerpt highlights 99% purity as another lever: high purity means less inert material and more consistent active methionine per unit of product.

The economic effect appears in the complete feed formula. When bioavailability is high and purity is tight, the required inclusion can be calculated with greater confidence. That can reduce safety margins, limit wasted nutrient, and improve the cost per unit of delivered methionine. In practice, the cheapest source per bag is not always the cheapest source per unit of animal-available methionine.

For producers and feed mills, the takeaway is to read the specification sheet alongside the formulation matrix. A 100% bioavailability claim and a 99% purity figure are not marketing decoration; they are inputs that change how much product is needed, how tightly the formula can be optimized, and ultimately how the economics of a complete feed stack up.